These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 10888253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
    Tyagi SC, Kumar S, Cassatt S, Parker JL.
    Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
    [Abstract] [Full Text] [Related]

  • 3. Remodeling of the vascular tunica media is essential for development of collateral vessels in the canine heart.
    Cai WJ, Kocsis E, Wu X, Rodríguez M, Luo X, Schaper W, Schaper J.
    Mol Cell Biochem; 2004 Sep; 264(1-2):201-10. PubMed ID: 15544049
    [Abstract] [Full Text] [Related]

  • 4. Remodeling of the adventitia during coronary arteriogenesis.
    Cai WJ, Koltai S, Kocsis E, Scholz D, Kostin S, Luo X, Schaper W, Schaper J.
    Am J Physiol Heart Circ Physiol; 2003 Jan; 284(1):H31-40. PubMed ID: 12388238
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes.
    Symeonidis C, Papakonstantinou E, Galli A, Tsinopoulos I, Mataftsi A, Batzios S, Dimitrakos SA.
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):741-9. PubMed ID: 23254483
    [Abstract] [Full Text] [Related]

  • 10. Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis.
    Cai WJ, Kocsis E, Luo X, Schaper W, Schaper J.
    Mol Cell Biochem; 2004 Sep; 264(1-2):193-200. PubMed ID: 15544048
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases modulated by protein kinase Cε mediate resistin-induced migration of human coronary artery smooth muscle cells.
    Ding Q, Chai H, Mahmood N, Tsao J, Mochly-Rosen D, Zhou W.
    J Vasc Surg; 2011 Apr; 53(4):1044-51. PubMed ID: 21277149
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [Abstract] [Full Text] [Related]

  • 13. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
    Berceli SA, Jiang Z, Klingman NV, Pfahnl CL, Abouhamze ZS, Frase CD, Schultz GS, Ozaki CK.
    J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
    [Abstract] [Full Text] [Related]

  • 14. Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development.
    Wang H, Liu C, Song Y, Gordon D, Alavi MZ, Moore S.
    Int J Mol Med; 2001 Jan; 7(1):105-12. PubMed ID: 11115618
    [Abstract] [Full Text] [Related]

  • 15. rd1 mouse retina shows imbalance in cellular distribution and levels of TIMP-1/MMP-9, TIMP-2/MMP-2 and sulfated glycosaminoglycans.
    Ahuja S, Ahuja P, Caffé AR, Ekstrom P, Abrahamson M, van Veen T.
    Ophthalmic Res; 2006 Jan; 38(3):125-36. PubMed ID: 16374054
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow mononuclear cell transplantation increases metalloproteinase-9 and 13 and decreases tissue inhibitors of metalloproteinase-1 and 2 expression in the liver of cholestatic rats.
    Nunes de Carvalho S, Helal-Neto E, de Andrade DC, Costa Cortez EA, Thole AA, Barja-Fidalgo C, de Carvalho L.
    Cells Tissues Organs; 2013 Jan; 198(2):139-48. PubMed ID: 23886643
    [Abstract] [Full Text] [Related]

  • 17. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
    Mountain DJ, Freeman MB, Kirkpatrick SS, Cook RB, Chalk JE, Stevens SL, Goldman MH, Grandas OH.
    Ann Vasc Surg; 2013 Apr; 27(3):337-45. PubMed ID: 23088810
    [Abstract] [Full Text] [Related]

  • 18. [Expression of matrix metalloproteinases and their inhibitors in the internal carotid artery wall in pathological tortuosity].
    Paltseva EM, Polyakova VO, Oskolkova SA, Abramyan AV, Ivanova AG, Krylova YS, Gavrilenko AV.
    Arkh Patol; 2016 Apr; 78(3):26-31. PubMed ID: 27296003
    [Abstract] [Full Text] [Related]

  • 19. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 20. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
    Liebetrau M, Burggraf D, Wunderlich N, Jäger G, Linz W, Hamann GF.
    Neurosci Lett; 2005 Mar 16; 376(3):205-9. PubMed ID: 15721222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.